Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.
Saia F, Lemos PA, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Sianos G, Smits PC, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW. Saia F, et al. Among authors: degertekin m. Heart. 2004 Oct;90(10):1183-8. doi: 10.1136/hrt.2003.025536. Heart. 2004. PMID: 15367519 Free PMC article.
Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease.
Arampatzis CA, Lemos PA, Tanabe K, Hoye A, Degertekin M, Saia F, Lee CH, Ruiter A, McFadden E, Sianos G, Smits PC, van der Giessen WJ, de Feijter P, van Domburg R, Serruys PW. Arampatzis CA, et al. Among authors: degertekin m. Am J Cardiol. 2003 Aug 1;92(3):327-9. doi: 10.1016/s0002-9149(03)00640-4. Am J Cardiol. 2003. PMID: 12888147 Clinical Trial.
Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size.
Regar E, Serruys PW, Bode C, Holubarsch C, Guermonprez JL, Wijns W, Bartorelli A, Constantini C, Degertekin M, Tanabe K, Disco C, Wuelfert E, Morice MC; RAVEL Study Group. Regar E, et al. Among authors: degertekin m. Circulation. 2002 Oct 8;106(15):1949-56. doi: 10.1161/01.cir.0000034045.36219.12. Circulation. 2002. PMID: 12370218 Free article. Clinical Trial.
Physician and Patient Preferences for Oral Anticoagulation Therapy Decision Making in Atrial Fibrillation: Results From a National Best-Worst Scaling Survey in Türkiye.
Kılıckesmez K, Aras D, Degertekin M, Ozer N, Hacibedel B, Helvacioglu K, Koc U, Ozdengulsun B, Dundar Ahi E, Ergene O. Kılıckesmez K, et al. Among authors: degertekin m. Clin Cardiol. 2024 Dec;47(12):e70038. doi: 10.1002/clc.70038. Clin Cardiol. 2024. PMID: 39654285 Free PMC article.
132 results